1. Home
  2. CFLT vs RGEN Comparison

CFLT vs RGEN Comparison

Compare CFLT & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CFLT
  • RGEN
  • Stock Information
  • Founded
  • CFLT 2014
  • RGEN 1981
  • Country
  • CFLT United States
  • RGEN United States
  • Employees
  • CFLT N/A
  • RGEN N/A
  • Industry
  • CFLT EDP Services
  • RGEN Medical/Dental Instruments
  • Sector
  • CFLT Technology
  • RGEN Health Care
  • Exchange
  • CFLT Nasdaq
  • RGEN Nasdaq
  • Market Cap
  • CFLT 8.1B
  • RGEN 8.0B
  • IPO Year
  • CFLT 2021
  • RGEN N/A
  • Fundamental
  • Price
  • CFLT $22.54
  • RGEN $126.50
  • Analyst Decision
  • CFLT Buy
  • RGEN Buy
  • Analyst Count
  • CFLT 30
  • RGEN 12
  • Target Price
  • CFLT $31.00
  • RGEN $172.67
  • AVG Volume (30 Days)
  • CFLT 7.1M
  • RGEN 815.5K
  • Earning Date
  • CFLT 04-30-2025
  • RGEN 04-29-2025
  • Dividend Yield
  • CFLT N/A
  • RGEN N/A
  • EPS Growth
  • CFLT N/A
  • RGEN N/A
  • EPS
  • CFLT N/A
  • RGEN N/A
  • Revenue
  • CFLT $1,017,525,000.00
  • RGEN $650,429,000.00
  • Revenue This Year
  • CFLT $21.73
  • RGEN $13.93
  • Revenue Next Year
  • CFLT $18.93
  • RGEN $14.35
  • P/E Ratio
  • CFLT N/A
  • RGEN N/A
  • Revenue Growth
  • CFLT 24.11
  • RGEN 4.88
  • 52 Week Low
  • CFLT $17.79
  • RGEN $102.97
  • 52 Week High
  • CFLT $37.90
  • RGEN $182.52
  • Technical
  • Relative Strength Index (RSI)
  • CFLT 51.12
  • RGEN 44.61
  • Support Level
  • CFLT $22.18
  • RGEN $123.10
  • Resistance Level
  • CFLT $23.66
  • RGEN $135.47
  • Average True Range (ATR)
  • CFLT 0.96
  • RGEN 6.98
  • MACD
  • CFLT 0.36
  • RGEN -0.97
  • Stochastic Oscillator
  • CFLT 63.70
  • RGEN 25.20

About CFLT Confluent Inc.

Confluent Inc provides a data streaming platform that enables customers to connect their applications, systems, and data layers and can be deployed as a fully managed cloud-native software-as-a-service (SaaS) offering. Its products include Confluent Cloud, a self-managed software offering, Confluent Platform, a managed service offering where the raw data resides inside a customer's cloud environment, and WarpStream, among others. Confluent also offers professional services and education services. The company generates revenue from the sale of subscriptions and services. Geographically, it generates a majority of its revenue from its business in the United States and the rest from International markets.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: